Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions - PubMed (original) (raw)

. 1990 Jun;15(6 Pt 2):699-703.

doi: 10.1161/01.hyp.15.6.699.

Affiliations

• PMID: 2141003
• DOI: 10.1161/01.hyp.15.6.699

Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions

W Auch-Schwelk et al. Hypertension. 1990 Jun.

Abstract

Endothelium-dependent contractions to acetylcholine and endothelium-independent contractions to oxygen-derived free radicals in the aorta of the spontaneously hypertensive rat (SHR) are mediated by an unidentified product of the cyclooxygenase pathway of arachidonic acid metabolism. To determine the role of thromboxane A2 (TXA2) or prostaglandin H2 (PGH2) in these contractions, rings of the thoracic aorta of SHR were suspended in organ chambers for measurement of isometric force. Acetylcholine caused endothelium-dependent contractions in quiescent rings from SHR aortas. Oxygen-derived free radicals generated with xanthine plus xanthine oxidase caused contractions in rings without endothelium. Dazoxiben (thromboxane synthetase inhibitor) did not affect contractions evoked by acetylcholine. AH 23,848, SQ 29,548, or R 68,070 (TXA2/PGH2 receptor antagonists) inhibited contractions to U 46,619 (a TXA2/PGH2 receptor agonist), acetylcholine, and oxygen-derived free radicals. Acetylcholine stimulated the release of prostacyclin from Wistar-Kyoto (WKY) rat and SHR aortas but not the release of other prostaglandins (PGE2, PGF2 alpha, TXA2). Oxygen-derived free radicals did not stimulate the release of prostaglandins from either SHR or WKY rat aortas. These results demonstrate that stimulation of TXA2/PGH2 receptors probably by PGH2 might be involved in endothelium-dependent contractions. Oxygen-derived free radicals, which might be an endothelium-derived contracting factor or factors, ultimately cause contraction by stimulation of TXA2/PGH2 receptors.

PubMed Disclaimer

Similar articles

• Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin.
  Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Gluais P, et al. Br J Pharmacol. 2005 Nov;146(6):834-45. doi: 10.1038/sj.bjp.0706390. Br J Pharmacol. 2005. PMID: 16158068 Free PMC article.
• Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
  Tesfamariam B. Tesfamariam B. J Hypertens. 1994 Jan;12(1):41-7. J Hypertens. 1994. PMID: 8157943
• Role of prostaglandins in acetylcholine-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats.
  Rapoport RM, Williams SP. Rapoport RM, et al. Hypertension. 1996 Jul;28(1):64-75. doi: 10.1161/01.hyp.28.1.64. Hypertension. 1996. PMID: 8675266
• Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors.
  Félétou M, Verbeuren TJ, Vanhoutte PM. Félétou M, et al. Br J Pharmacol. 2009 Feb;156(4):563-74. doi: 10.1111/j.1476-5381.2008.00060.x. Epub 2009 Jan 19. Br J Pharmacol. 2009. PMID: 19154435 Free PMC article. Review.
• Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions.
  Tang EH, Vanhoutte PM. Tang EH, et al. Pharmacol Ther. 2009 May;122(2):140-9. doi: 10.1016/j.pharmthera.2009.02.006. Epub 2009 Mar 12. Pharmacol Ther. 2009. PMID: 19285526 Review.

Cited by

• Catechins: Protective mechanism of antioxidant stress in atherosclerosis.
  Sheng Y, Sun Y, Tang Y, Yu Y, Wang J, Zheng F, Li Y, Sun Y. Sheng Y, et al. Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
• Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.
  Alotaibi M, Shao J, Pauciulo MW, Nichols WC, Hemnes AR, Malhotra A, Kim NH, Yuan JX, Fernandes T, Kerr KM, Alshawabkeh L, Desai AA, Bujor AM, Lafyatis R, Watrous JD, Long T, Cheng S, Chan SY, Jain M. Alotaibi M, et al. Chest. 2023 Jan;163(1):204-215. doi: 10.1016/j.chest.2022.08.2230. Epub 2022 Sep 7. Chest. 2023. PMID: 36087794 Free PMC article.
• Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids.
  Artru F, McPhail MJW, Triantafyllou E, Trovato FM. Artru F, et al. Front Immunol. 2022 Mar 31;13:867261. doi: 10.3389/fimmu.2022.867261. eCollection 2022. Front Immunol. 2022. PMID: 35432367 Free PMC article. Review.
• Thromboxane A2 receptor antagonist (ONO-8809) attenuates renal disorders caused by salt overload in stroke-prone spontaneously hypertensive rats.
  Nagatani Y, Higashino T, Kinoshita K, Higashino H. Nagatani Y, et al. Clin Exp Pharmacol Physiol. 2021 Oct;48(10):1391-1401. doi: 10.1111/1440-1681.13543. Epub 2021 Jul 5. Clin Exp Pharmacol Physiol. 2021. PMID: 34152603 Free PMC article.
• Endothelial cyclooxygenase-1 paradoxically drives local vasoconstriction and atherogenesis despite underpinning prostacyclin generation.
  Mitchell JA, Shala F, Pires MEL, Loy RY, Ravendren A, Benson J, Urquhart P, Nicolaou A, Herschman HR, Kirkby NS. Mitchell JA, et al. Sci Adv. 2021 Mar 19;7(12):eabf6054. doi: 10.1126/sciadv.abf6054. Print 2021 Mar. Sci Adv. 2021. PMID: 33741600 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.